Lyra Therapeutics, Inc.
LYRA
Revenue
25.00k
▼-158.00k▼-86.34%
3 Months ChangeAssets
43.71M
▼-8.86M▼-16.86%
3 Months ChangeLiabilities
48.04M
▼-2.91M▼-5.72%
3 Months ChangeFree Cash Flow
-24.60M
▼-8.71M▼-54.79%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-27
Form 8-K
ID: 0001193125-26-083251
2026-02-06
Form 8-K
ID: 0001193125-26-041191
2026-01-12
Form 8-K
ID: 0001193125-26-009772
2025-11-12
Form 10-Q
ID: 0001193125-25-277564
2025-11-12
Form 8-K
ID: 0001193125-25-277515
2025-09-04
Form 8-K
ID: 0001193125-25-195384
2025-08-22
Form 8-K
ID: 0001193125-25-186437
2025-08-12
Form 10-Q
ID: 0000950170-25-107367
2025-08-12
Form 8-K
ID: 0000950170-25-107339
2025-08-01
Form 8-K
ID: 0001193125-25-171647